Figure 1.1

Distribution of NHANES participants with diabetes, congestive heart failure, & markers of CKD, with GFR estimated by MDRD & CKD-EPI equations
[Download]

Figure 1.2

Odds ratios of CKD in NHANES 2001–2008 participants, by risk factor & method used to estimate eGFR
[Download]

Figure 1.3

Cumulative eGFR distribution curves of NHANES 2001–2008 participants, by method used to estimate GFR
[Download]

Figure 1.4

Prevalence of comorbidity in NHANES 2001–2008 participants, by risk factor, eGFR, & method used to estimate GFR
[Download]

Figure 1.5

Prevalence of comorbidity in NHANES 2001–2008 participants, by risk factor, expanded eGFR categories, & method used to estimate GFR
[Download]

Figure 1.6

Distribution of NHANES 2001–2008 participants, by age, eGFR, & method used to estimate GFR
[Download]

Figure 1.7

Prevalence of comorbidity in NHANES 2001–2008 participants, by risk factor & albumin/creatinine ratio
[Download]

Figure 1.8

Predicting death: sensitivity & specificity of different eGFR thresholds: MDRD equation, NHANES 1988–1994 participants
[Download]

Figure 1.9

Predicting death: sensitivity & specificity of different eGFR thresholds: CKD-EPI equation, NHANES 1988–1994 participants
[Download]

Figure 1.10

Predicting death: sensitivity & specificity of different ACR thresholds, NHANES 1988–1994 participants
[Download]

Figure 1.11

Mortality rates in NHANES 1999–2004 participants, by eGFR: MDRD equation
[Download]

Figure 1.12

Mortality rates in NHANES 1999–2004 participants, by eGFR: CKD-EPI equation
[Download]

Table A

Prevalence & odds ratios of CKD in NHANES 2001–2008 participants, by ACR & method used to estimate GFR, age, gender, race/ethnicity, & risk factor (percent of participants)
[Download]

Table B

Awareness, treatment, & control of hypertension, hypercholesterolemia, HDL, total cholesterol, & diabetes, by ACR, eGFR, & method used to estimate GFR (percent of NHANES participants)
[Download]